MTX-474

N/A

Report date: 2026/05/02 20:00:18
First In Class

Base Information

Drug NameMTX-474
Drug Alias NameMTX-474
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionEphrin-B2 signaling neutralization
TargetsEphrin-B2
Therapy Area/IndicationsFibrosisScleroderma, Diffuse
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMediar Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesMediar Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsFibrosisScleroderma, Diffuse
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A